Information about the Moderna COVID-19 Vaccine

Clinical trials for the Moderna vaccine included people from the following racial, ethnic, age, and sex categories:

Race

• 79% White
• 10% African American
• 5% Asian
• <3% other races/ethnicities
• <1% American Indian or Alaska Native
• <1% Native Hawaiian or Other Pacific Islander

Ethnicity

• 79% not Hispanic or Latino
• 20% Hispanic or Latino
• 1% unknown

Sex

Age

• 75% 18 through 64 years
• 25% 65 years and older

Twenty-two percent (22%) of people who participated in the clinical trials had at least one condition that put them at risk of severe illness from COVID-19. The most frequent underlying medical conditions among participants were lung disease, heart disease, obesity, diabetes, liver disease, or HIV infection. Four percent (4%) of participants had two or more high-risk conditions.
Most people who participated in the trials (82%) were considered to have an occupational risk of exposure, with 25% of them being healthcare workers.

Public link

Please use the above public link if you want to share this noodl on another website.